The legal battle between Canary Wharf Group and the European Medicines Agency (EMA) over whether the legal "frustration" caused by Brexit means the EMA can break its £500m 25-year lease has caught the attention of almost every legal professional in the property industry. The High Court ruled in favour of Canary Wharf in February, but Ben Hatton, director of property litigation at Clifford Chance, which acted for the property company, would not be surprised if the story does not end there. The EMA has until 15 April to file an application to the Court of Appeal.
展开▼
